What is Natera?
Natera is a genetic testing and diagnostics company serving providers, patients, payers, hospitals, labs, and life-sciences operators.
- Category
- Genetic testing and diagnostics
- Headquarters
- Austin, TX
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; Nasdaq: NTRA
What is Natera?
Natera is a genetic testing and diagnostics company headquartered in Austin, TX.
Natera operates in genetic testing and diagnostics and is included here as a public company account for sales research and directory coverage. Its official website and investor-facing materials position the business around Panorama, Signatera, Horizon, with a buying center that usually spans finance, operations, IT, procurement, legal, and line-of-business leadership.
For sellers, Natera is useful to profile because public-company signals make account planning more concrete. Current annual reports, investor presentations, earnings releases, job posts, product launches, facility expansion, and partner announcements are stronger signals than stale third-party summaries.
What does Natera offer?
Natera's profile centers on Panorama, Signatera, Horizon, Organ health testing.
- Panorama· Genetic testing and diagnostics
- Signatera· Genetic testing and diagnostics
- Horizon· Genetic testing and diagnostics
- Organ health testing· Genetic testing and diagnostics
- Women's health· Genetic testing and diagnostics
- Oncology monitoring· Genetic testing and diagnostics
How does Natera make money?
Natera makes money through commercial activity tied to genetic testing and diagnostics.
Natera makes money through commercial activity tied to genetic testing and diagnostics. Depending on the operating unit, revenue may come from product sales, subscriptions, transaction fees, services, usage, occupancy, routing density, channel programs, or long-term customer contracts.
The practical growth levers are market expansion, pricing, utilization, operating efficiency, customer retention, product attach, supply-chain execution, and capital allocation. Relevant outreach should connect to measurable initiatives such as margin improvement, uptime, automation, compliance, customer experience, field productivity, or data quality.
Who leads Natera?
Natera's named executives should be verified on the official leadership or investor-relations page before outreach.
- Natera executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Natera finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, and budget discipline.
- Natera operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operational-improvement purchases.
How do you contact Natera's leadership?
Natera should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.natera.comHow is Natera funded?
Natera's current status is Public company; Nasdaq: NTRA.
Natera's current capital profile is best understood through its listed public-company status: Public company; Nasdaq: NTRA. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capital expenditure plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor relations page and current exchange filings. Budget timing should be inferred from current initiatives, leadership priorities, geographic expansion, product launches, facility investments, and earnings-call commentary.
How did Natera get here?
Natera's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingNatera is foundedThe company begins building in genetic testing and diagnostics.
- Scale-upCommercial footprint expandsNatera broadens its product, customer, or geographic reach.
- Public marketsPublic company; Nasdaq: NTRAPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are Natera's competitors?
Natera competes with larger incumbents and focused specialists in genetic testing and diagnostics.
- MedtronicGlobal medical technology incumbent.
- Boston ScientificLarge interventional medical-device competitor.
- AbbottHealthcare company spanning diagnostics, devices, nutrition, and diabetes care.
- StrykerOrthopedics, neurotechnology, and surgical-equipment company.
- Cardinal HealthHealthcare distribution and services provider.
Natera — frequently asked questions
